Valneva COVID-19 vaccine: What do we know about it?
VLA2001, a new COVID-19 vaccine developed by Valneva, a French biotechnology company, using traditional methods, has now received condi...
Most people don’t know these possible signs of early Alzheimer’s
If you're not familiar with the term "mild cognitive impairment," you're not the only one. More than 80% of Americans aren't familiar w...
Marijuana may make sleep worse, especially for regular users, study finds
It's a common assumption among marijuana users: Using weed will help you fall asleep and stay asleep. Scientists, however, aren't so su...
Early signs suggest the Omicron wave is peaking in some parts of the US, but relief is far from near
The Omicron surge has driven Covid-19 cases and hospitalizations to record highs in the United States. This week, however, officials ha...
Many colleges will require the Covid vaccine—here are some of the challenges ahead
Every year, colleges across the country require students to get vaccinations for diseases such as Measles and Tetanus. Now, one year into the coronavirus pandemic, vaccines against the virus are becoming available for college-age students.
Tweaked COVID vaccines in testing aim to fend off variants
Dozens of Americans are rolling up their sleeves for a third dose of COVID-19 vaccine -- this time, shots tweaked to guard against a wo...
On average 1759 new infections per day
The development of the epidemic is monitored by using a 7-day average and in comparison to the infection events of the previous week. This method enables us to clearly show the respective trends, regardless of the fluctuations in the daily figures.
On average 69 new hospital admissions per day last week
The development of the epidemic is monitored by using a 7-day average and in comparison to the infection events of the previous week. This method enables us to clearly show the respective trends, regardless of the fluctuations in the daily figures.
Infections and hospital admissions are stabilising, deaths are increasing
The development of the epidemic is monitored by using a 7-day average and in comparison to the infection events of the previous week. This method enables us to clearly show the respective trends, regardless of the fluctuations in the daily figures.
Coronalert available for all
After having been rolled out to more than 10,000 users, the Coronalert application is now accessible to the entire Belgian population. This application is one of the tools used in the fight against Covid-19.